Alzheimer's disease neuropathological changeDisease1 paperLatestNov 2025: 0Dec 2025: 8Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 2Oct 2026: 011The Lancet NeurologyHumans·9 SepPlasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studiesCognitive impairmentThe Lancet NeurologyReview·9 SepClinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological changeAlzheimer's diseaseResearch SquareHumansPreprint·3 SepPre-dementia clinical trajectories associated with neuronal α-synuclein neuropathologic change: a retrospective cohort studyDementiaAAIC 2025 AbstractHumans·26 DecDifferential performance of plasma p ‐tau217 in detecting intermediate vs high Alzheimer's disease neuropathologic changeBiomarkersAAIC 2025 AbstractHumans·25 DecAlzheimer's Disease and concomitant pathologies in SuperAgersPopulationsAAIC 2025 AbstractHumans·24 DecLimbic‐predominant age‐related TDP‐43 encephalopathy, but Not Alzheimer's Disease, neuropathological changes are associated with Physical Performance Decline in the Oldest Old: Insights from The 90+ StudyPopulationsAAIC 2025 AbstractHumans·24 DecCognitively resilient individuals show enrichment for MS4A gene SNPs and postmortem amyloid‐responsive microgliaMechanismsAAIC 2025 AbstractHumans·24 DecSex differences mixed neuropathologies to Alzheimer's disease and cognitive abilitiesPopulationsAAIC 2025 AbstractHumans·23 DecDifferential performance of plasma p ‐tau217 in detecting intermediate vs high Alzheimer's disease neuropathologic changeBiomarkersAAIC 2025 AbstractHumans·23 DecAssociations of hearing loss and hearing aid use with brain pathologies at autopsy in a community‐based cohortPopulations
The Lancet NeurologyHumans·9 SepPlasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studiesCognitive impairment
The Lancet NeurologyReview·9 SepClinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological changeAlzheimer's disease
Research SquareHumansPreprint·3 SepPre-dementia clinical trajectories associated with neuronal α-synuclein neuropathologic change: a retrospective cohort studyDementia
AAIC 2025 AbstractHumans·26 DecDifferential performance of plasma p ‐tau217 in detecting intermediate vs high Alzheimer's disease neuropathologic changeBiomarkers
AAIC 2025 AbstractHumans·25 DecAlzheimer's Disease and concomitant pathologies in SuperAgersPopulations
AAIC 2025 AbstractHumans·24 DecLimbic‐predominant age‐related TDP‐43 encephalopathy, but Not Alzheimer's Disease, neuropathological changes are associated with Physical Performance Decline in the Oldest Old: Insights from The 90+ StudyPopulations
AAIC 2025 AbstractHumans·24 DecCognitively resilient individuals show enrichment for MS4A gene SNPs and postmortem amyloid‐responsive microgliaMechanisms
AAIC 2025 AbstractHumans·24 DecSex differences mixed neuropathologies to Alzheimer's disease and cognitive abilitiesPopulations
AAIC 2025 AbstractHumans·23 DecDifferential performance of plasma p ‐tau217 in detecting intermediate vs high Alzheimer's disease neuropathologic changeBiomarkers
AAIC 2025 AbstractHumans·23 DecAssociations of hearing loss and hearing aid use with brain pathologies at autopsy in a community‐based cohortPopulations